Alert Added Successfully

Endocrinology


               
Article Title Year Authour(s) Journal Subject Expert Rating Evidence Ranking
1. Availability of Inhaled Insulin Promotes Greater Perceived Acceptance of Insulin Therapy in Patients With Type 2 Diabetes 2005 Freemantle, N., Blonde, L., Duhot, D. Diabetes Care Endocrinology A
2. Systematic Review and Meta-analysis of Short-Acting Insulin Analogues in Patients With Diabetes Mellitus 2005 Plank, J., Siebenhofer, A., Berghold, A. Arch Intern Med Endocrinology A
3. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes: A Meta-analysis of Randomized Clinical Trials 2005 Abuissa, H., Jones, P.G., Marso, S.P. J Am Coll Cardiol Endocrinology A
4. Comparison of Basal Insulin Added to Oral Agents Versus Twice-Daily Premixed Insulin as Initial Insulin Therapy for Type 2 Diabetes 2005 Janka, H.U., Kliebe-Frisch, C., Plewe, G. Diabetes Care Endocrinology A
5. Should Diabetes Be Considered a Coronary Heart Disease Risk Equivalent? Results From 25 Years of Follow-up in the Renfrew and Paisley Survey 2005 Whiteley, L., Hole, D., Padmanabhan, S. Diabetes Care Endocrinology B
6. Vascular Risk Factors and Diabetic Neuropathy 2005 Tesfaye, S., for the EURODIAB Prospective Complications Study Group. N Engl J Med Endocrinology B
7. Relief of Painful Diabetic Peripheral Neuropathy With Pregabalin: A Randomized, Placebo-controlled Trial 2005 Richter, R.W., Portenoy, R., Sharma, U. J Pain Endocrinology A
8. A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia 2005 Goldberg, R.B., Tan, M.H., Kendall, D.M. Diabetes Care Endocrinology A
9. The Metabolic Syndrome: Time for a Critical Appraisal: Joint Statement From the American Diabetes Association and the European Association for the Study of Diabetes 2005 Kahn, R., Ferrannini, E., Buse, J. Diabetes Care Endocrinology C
10. The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial 2005 Orchard, T.J., for the Diabetes Prevention Program Research Group. Ann Intern Med Endocrinology A
11. Morphine, Gabapentin, or Their Combination for Neuropathic Pain 2005 GiIron, I., Bailey, J.M., Tu, D. N Engl J Med Endocrinology A
12. Aspirin Use Among Adults With Diabetes: Recent Trends and Emerging Sex Disparities 2004 Persell, S.D., Baker, D.W. Arch Intern Med Endocrinology B
13. Normal Fasting Plasma Glucose Levels and Type 2 Diabetes in Young Men 2005 Tirosh, A., for the Israeli Diabetes Research Group. N Engl J Med Endocrinology B
14. Impact of Intensive Lifestyle and Metformin Therapy on Cardiovascular Disease Risk Factors in the Diabetes Prevention Program 2005 Ratner, R., for the Diabetes Prevention Program Research Group. Diabetes Care Endocrinology A
15. Improved Clinical Outcomes Associated With Metformin in Patients With Diabetes and Heart Failure 2005 Eurich, D.T., Majumdar, S.R., McAlister, F.A. Diabetes Care Endocrinology B
16. Initiating Insulin Therapy in Type 2 Diabetes: A Comparison of Biphasic and Basal Insulin Analogs 2005 Raskin, P., for the INITIATE Study Group. Diabetes Care Endocrinology A
17. Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes 2005 Crowther, C.A., for the Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. N Engl J Med Endocrinology A
18. Insulin Needs After CD3-Antibody Therapy in New-Onset Type 1 Diabetes 2005 Keymeulen, B., Vandemeulebroucke, E., Ziegler, A.G. N Engl J Med Endocrinology A
19. Exenatide Versus Insulin Glargine in Patients With Suboptimally Controlled Type 2 Diabetes: A Randomized Trial 2005 Heine, R.J., for the GWAA Study Group. Ann Intern Med Endocrinology A
20. Sex Disparities in Treatment of Cardiac Risk Factors in Patients With Type 2 Diabetes 2005 Wexler, D.J., Nathan, D.M., Grant, R.W. Diabetes Care Endocrinology B
21. Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) 2005 Whelton, P.K., for the ALLHAT Collaborative Research Group. Arch Intern Med Endocrinology A
22. Inhaled Insulin Improves Glycemic Control When Substituted for or Added to Oral Combination Therapy in Type 2 Diabetes: A Randomized Controlled Trial 2005 Rosenstock, J., Zinman, B., Murphy, L.J. Ann Intern Med Endocrinology A
23. Beneficial Postprandial Effect of a Small Amount of Alcohol on Diabetes and Cardiovascular Risk Factors: Modification by Insulin Resistance 2005 Greenfield, J.R., Samaras, K., Hayward, C.S. J Clin Endocrinol Metab Endocrinology B